glp-1 shortage canada news today GLP-1 prescription trends through March 2026 GLP-1 Receptor Agonist Market to

References: Alfaiz, A

Theyre working hard, but the biology of weight is complex

Design In the obesity trial, 338 participants (mean age 48 years, 48% women, mean BMI 37.3 kg/m 2 ) were randomised (2:1:1:1:1:2:2) to retatrutide 1 mg, 4 mg (titration), 4 mg (no titration), 8 mg (slow titration), 8 mg (fast titration), 12 mg or placebo over 48 weeks [45]

A gentler dosing approach designed for patients who prefer steadier, more sustainable changes over time

Fructo-oligosaccharides (FOS) may be used in a variety of baked foods, offering benefits such as increased fiber content, improved texture and reduced sugar levels, said Jacob Hanzon, R&D department manager for Galam, a global ingredients manufacturer with production sites in Israel, Germany and Spain and a distribution center in Ohio

Weight Loss Effect of Glucagon-Like Peptide-1 Mimetics on Obese/Overweight Adults Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials